Last Close
Mar 18  •  12:59PM ET
4.86
Dollar change
-0.01
Percentage change
-0.10
%
Index- P/E- EPS (ttm)-12.85 Insider Own- Shs Outstand4.47M Perf Week-4.06%
Market Cap21.76M Forward P/E6.08 EPS next Y0.80 Insider Trans- Shs Float- Perf Month-18.44%
Enterprise Value57.43M PEG- EPS next Q-6.05 Inst Own46.64% Short Float- Perf Quarter-30.82%
Income-56.70M P/S0.25 EPS this Y-7200.00% Inst Trans5.19% Short Ratio1.00 Perf Half Y0.33%
Sales86.55M P/B1.58 EPS next Y105.48% ROA-54.86% Short Interest0.05M Perf YTD-27.26%
Book/sh3.07 P/C2.53 EPS next 5Y- ROE-147.13% 52W High9.46 -48.56% Perf Year-27.79%
Cash/sh1.93 P/FCF3.98 EPS past 3/5Y-77.14% -44.59% ROIC-100.38% 52W Low2.81 72.95% Perf 3Y-83.84%
Dividend Est.- EV/EBITDA9.57 Sales past 3/5Y-8.60% -3.25% Gross Margin53.01% Volatility13.54% 8.69% Perf 5Y-92.31%
Dividend TTM- EV/Sales0.66 EPS Y/Y TTM-350.49% Oper. Margin0.12% ATR (14)0.47 Perf 10Y-82.44%
Dividend Ex-Date- Quick Ratio1.25 Sales Y/Y TTM-8.06% Profit Margin-65.51% RSI (14)39.81 Recom2.00
Dividend Gr. 3/5Y- - Current Ratio2.20 EPS Q/Q-16057.50% SMA20-11.16% Beta1.49 Target Price6.00
Payout- Debt/Eq3.23 Sales Q/Q-3.34% SMA50-13.62% Rel Volume0.74 Prev Close4.87
Employees339 LT Debt/Eq3.11 EarningsMar 12 BMO SMA200-9.58% Avg Volume45.57K Price4.86
IPODec 07, 2000 Option/ShortYes / Yes EPS/Sales Surpr.-100.00% 2.75% Trades Volume18,882 Change-0.10%
Date Action Analyst Rating Change Price Target Change
Apr-09-25Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Mar-10-23Upgrade The Benchmark Company Speculative Buy → Buy $3 → $4
Jan-07-21Upgrade The Benchmark Company Speculative Buy → Buy
Dec-09-20Initiated Northland Capital Outperform $6
Nov-10-20Initiated KeyBanc Capital Markets Overweight $6
Jul-08-19Downgrade Janney Buy → Neutral $2
Jan-24-18Reiterated Janney Buy $5 → $8
Jan-23-18Reiterated The Benchmark Company Buy $6 → $10
Nov-17-16Initiated Singular Research Buy $5.50
Jul-28-15Initiated The Benchmark Company Buy $8
Mar-12-26 03:01PM
12:58PM
07:47AM
07:30AM
Mar-06-26 04:01PM
07:30AM Loading…
Mar-03-26 07:30AM
Feb-26-26 07:30AM
Feb-10-26 07:30AM
Feb-03-26 05:35AM
Jan-30-26 06:49AM
Jan-29-26 04:30PM
Dec-17-25 07:30AM
Nov-06-25 02:05PM
07:31AM
07:00AM
08:00AM Loading…
Oct-30-25 08:00AM
Sep-16-25 07:00AM
Sep-09-25 07:00AM
Aug-12-25 03:02AM
Aug-11-25 07:20AM
07:00AM
Aug-08-25 09:33AM
Aug-04-25 04:30PM
Jul-17-25 07:00AM
Jun-02-25 04:57PM
May-14-25 09:14AM
May-13-25 03:03AM
May-12-25 11:28PM
07:13AM
07:00AM
09:52AM Loading…
May-09-25 09:52AM
May-05-25 04:45PM
Apr-10-25 04:45PM
Mar-13-25 01:18AM
Mar-12-25 04:00PM
07:21AM
Feb-24-25 04:45PM
11:00AM
Jan-21-25 09:00AM
Jan-13-25 05:52PM
Nov-08-24 02:08AM
Nov-07-24 07:12AM
07:00AM
Nov-06-24 07:50AM
Oct-29-24 05:00PM
Oct-09-24 05:43PM
Oct-03-24 08:00AM
Sep-18-24 07:30AM
Sep-17-24 08:00AM
Sep-05-24 04:05PM
Aug-08-24 08:37AM
08:30AM
Aug-02-24 08:00AM
Jun-06-24 04:05PM
May-23-24 04:05PM
May-16-24 04:05PM
May-08-24 10:14AM
03:03AM
May-07-24 11:56AM
08:41AM
08:15AM
07:13AM
07:00AM
Apr-29-24 08:45AM
Apr-09-24 09:00AM
Mar-12-24 10:30AM
Mar-11-24 08:00AM
Mar-08-24 10:48AM
Mar-07-24 10:51PM
01:56PM
12:53PM
07:32AM
07:00AM
Mar-06-24 08:30AM
Feb-27-24 05:10PM
Nov-20-23 04:40PM
Nov-09-23 04:30PM
02:28PM
Nov-07-23 09:58PM
08:00AM
07:28AM
07:00AM
Nov-06-23 04:30PM
Oct-30-23 09:00AM
Sep-18-23 08:57AM
Aug-15-23 10:20AM
Aug-08-23 09:43PM
09:15AM
08:05AM
07:18AM
Aug-03-23 06:30PM
Jul-27-23 06:36PM
Jun-22-23 07:55AM
Jun-21-23 08:50AM
Jun-20-23 08:01AM
Jun-13-23 12:21PM
May-25-23 08:50AM
May-24-23 08:26AM
May-23-23 10:17AM
May-09-23 09:40AM
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Snider WilliamDirectorMar 16 '26Buy4.9912,52562,50023,525Mar 18 07:31 AM
Snider WilliamDirectorMar 17 '26Buy4.858,47541,10432,000Mar 18 07:31 AM
Duke John DChief Executive OfficerMar 16 '26Buy5.015,00025,050105,000Mar 17 05:56 PM